I propose that the tissue-specific accumulation of HNE/MDA adducts on ETC subunits isn't just a byproduct of oxidative stress; it’s a direct evolutionary selection pressure that drives the fixation of specific mtDNA heteroplasmies. My hypothesis is that mitochondrial protein carbonylation at key catalytic thiols forces a metabolic shift. This shift favors the translation of mtDNA variants with "damage-tolerant" motifs, even when that comes at the expense of overall bioenergetic efficiency.

Existing literature notes the damage to NDUFS1 and SDHA [PMC2080815], but researchers often treat this as passive deterioration. I suspect there’s an active, maladaptive feedback loop at play:

1. The Adduct-Translation Link: When HNE/MDA alkylates the Rieske Fe-S protein or NDUFS subunits, the mitochondrial matrix triggers a compensatory retrograde signaling response, upregulating transcription to restore ETC stoichiometry.

2. The Bottleneck Effect: In high-lipid-turnover cells like muscle or neurons, persistent adducting of the mitochondrial translation machinery—particularly ribosomal proteins sensitive to HNE [PMC12121948]—creates a "proteostatic threshold." Under this pressure, the cell preferentially translates transcripts that are either shorter or less reliant on heavily adducted chaperones for assembly.

3. Selection for Dysfunction: mtDNA heteroplasmies that produce truncated subunits or amino acid substitutions—which potentially shift the pKa of neighboring nucleophilic residues to reduce HNE binding—are favored during mitochondrial fission/fusion cycles. This suggests that the rise in mtDNA mutations after age 70 isn’t just stochastic; it’s a rapid evolutionary pivot to an environment clogged with lipid-peroxidation-modified scaffolds.

Testable Predictions:

• Cross-Link Sensitivity: If this is correct, mtDNA mutations shouldn't be random. They should correlate with the lipid-susceptibility signatures of the proteins they encode. We should see high-frequency heteroplasmy in proteins with the highest ratio of HNE-binding per turn.
• Reversal Experiments: Using a mito-targeted aldehyde dehydrogenase (e.g., an ALDH2 transgene) in mtDNA mutator mice should do more than prevent adduct formation; it should actually halt the selection rate of heteroplasmic variants. This would confirm that protein damage is the primary engine driving mitochondrial genome drift.
• Proteomic/Genomic Mapping: With high-resolution mass spectrometry and single-cell mtDNA sequencing, we should be able to show that "protected" mitochondrial genotypes exist in organelles with significantly lower HNE-protein cross-linking density than those undergoing rapid drift.

This changes how we look at aging: we aren't just accumulating cellular debris. We are actively pruning our mitochondrial genome to survive a matrix polluted by lipid oxidation. Therapies like SkQ1 [aging-us.com/article/101174/text] might be failing in late-stage intervention precisely because these "damage-tolerant" heteroplasmies are already fixed. To see results, we need to clear these protein adducts before the onset of heteroplasmic drift.